Literature DB >> 12513686

Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes.

Anthony J Barron1, Stephen G Finn, Stephen J Fuller.   

Abstract

Extracellular-signal-regulated protein kinases (ERKs) are activated rapidly and transiently in response to phenylephrine (PE) and endothelin-1 (ET-1) in cardiac myocytes, but whether this is linked to the subsequent development of the hypertrophic phenotype remains equivocal. To investigate this, we examined the dependence of the hypertrophic response on the length of exposure to PE in neonatal myocyte cultures. In addition to the initial transient activation of ERKs (maximum at 5-10 min), PE (10 microM) induced a second, more prolonged peak of activity several hours later. The activity of a transfected atrial natriuretic factor-luciferase reporter gene was increased 10- to 24-fold by PE. This response was inhibited by the alpha(1)-antagonist prazosin (100 nM) and by U0126 (10 microM) and PD184352 (1 microM), inhibitors of ERK activation, irrespective of whether these were added before or up to 24 h after the addition of PE. Prazosin had no effect on ET-1 (50 nM)-stimulated atrial natriuretic factor-luciferase activity. Protein synthesis was enhanced by 35+/-6% by PE, and this was blocked by prazosin added 1 h after the addition of PE, but decreased only by half when added 8 h after PE. Similarly, PE (48 h) increased myocyte area by 49% and this was prevented by prazosin added 1 h after PE, but decreased only by half when added at 24 h. These results demonstrate that prolonged exposure to PE is required to elicit alterations in gene expression, protein synthesis and cell size, characteristic of hypertrophied myocytes, and they confirm that the initial peak of ERK activity is insufficient to trigger hypertrophic responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12513686      PMCID: PMC1223261          DOI: 10.1042/BJ20021395

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.

Authors:  O F Bueno; L J De Windt; K M Tymitz; S A Witt; T R Kimball; R Klevitsky; T E Hewett; S P Jones; D J Lefer; C F Peng; R N Kitsis; J D Molkentin
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

2.  Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases.

Authors:  G Choukroun; R Hajjar; S Fry; F del Monte; S Haq; J L Guerrero; M Picard; A Rosenzweig; T Force
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

3.  Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.

Authors:  T L Yue; J L Gu; C Wang; A D Reith; J C Lee; R C Mirabile; R Kreutz; Y Wang; B Maleeff; A A Parsons; E H Ohlstein
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

4.  Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.

Authors:  T Ueyama; S Kawashima; T Sakoda; Y Rikitake; T Ishida; M Kawai; T Yamashita; S Ishido; H Hotta; M Yokoyama
Journal:  J Mol Cell Cardiol       Date:  2000-06       Impact factor: 5.000

5.  Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.

Authors:  H Aoki; M Richmond; S Izumo; J Sadoshima
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

6.  Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus.

Authors:  S Kamakura; T Moriguchi; E Nishida
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

7.  Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

Authors:  R L Nicol; N Frey; G Pearson; M Cobb; J Richardson; E N Olson
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

Review 8.  Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists.

Authors:  A Clerk; P H Sugden
Journal:  Am J Cardiol       Date:  1999-06-17       Impact factor: 2.778

9.  Differential regulation of parallel mitogen-activated protein kinases in cardiac myocytes revealed by phosphatase inhibition.

Authors:  M B Andersson; A J Ketterman; M A Bogoyevitch
Journal:  Biochem Biophys Res Commun       Date:  1998-10-09       Impact factor: 3.575

10.  The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.

Authors:  S J Cook; N Aziz; M McMahon
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more
  11 in total

1.  Sex differences in cardiomyocyte connexin43 expression.

Authors:  Brian L Stauffer; Rebecca D Sobus; Carmen C Sucharov
Journal:  J Cardiovasc Pharmacol       Date:  2011-07       Impact factor: 3.105

2.  Efficient experimental design and analysis of real-time PCR assays.

Authors:  Kwokyin Hui; Zhong-Ping Feng
Journal:  Channels (Austin)       Date:  2013-03-19       Impact factor: 2.581

3.  Adenosine kinase regulation of cardiomyocyte hypertrophy.

Authors:  John T Fassett; Xinli Hu; Xin Xu; Zhongbing Lu; Ping Zhang; Yingjie Chen; Robert J Bache
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 4.  New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

5.  A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.

Authors:  Raghu S Nagalingam; Nagalingam R Sundaresan; Mahesh P Gupta; David L Geenen; R John Solaro; Madhu Gupta
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

Review 6.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

7.  Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice.

Authors:  Nagalingam R Sundaresan; Madhu Gupta; Gene Kim; Senthilkumar B Rajamohan; Ayman Isbatan; Mahesh P Gupta
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808

Review 8.  Rebuilding the post-infarcted myocardium by activating 'physiologic' hypertrophic signaling pathways: the thyroid hormone paradigm.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2008-09-05       Impact factor: 4.214

9.  Automated imaging reveals a concentration dependent delay in reversibility of cardiac myocyte hypertrophy.

Authors:  Karen A Ryall; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2012-05-08       Impact factor: 5.000

10.  Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway.

Authors:  Dongdong Qian; Jing Tian; Sining Wang; Xiaoli Shan; Pei Zhao; Huihua Chen; Ming Xu; Wei Guo; Chen Zhang; Rong Lu
Journal:  BMC Complement Med Ther       Date:  2022-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.